Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Eye shielding during total body irradiation for bone marrow transplantation in children transplanted for a hematological disorder: risks and benefits.
van Kempen-Harteveld ML, van Weel-Sipman MH, Emmens C, Noordijk EM, van der Tweel I, Révész T, Struikmans H, Kal HB, van der Does-van den Berg A, Vossen JM. van Kempen-Harteveld ML, et al. Among authors: noordijk em. Bone Marrow Transplant. 2003 Jun;31(12):1151-6. doi: 10.1038/sj.bmt.1704076. Bone Marrow Transplant. 2003. PMID: 12796795
Results of hematopoietic stem cell transplantation after treatment with different high-dose total-body irradiation regimens in five Dutch centers.
van Kempen-Harteveld ML, Brand R, Kal HB, Verdonck LF, Hofman P, Schattenberg AV, van der Maazen RW, Cornelissen JJ, Eijkenboom WM, van der Lelie JP, Oldenburger F, Barge RM, van Biezen A, Vossen JM, Noordijk EM, Struikmans H. van Kempen-Harteveld ML, et al. Among authors: noordijk em. Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1444-54. doi: 10.1016/j.ijrobp.2007.11.072. Epub 2008 Mar 4. Int J Radiat Oncol Biol Phys. 2008. PMID: 18294781
Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost' trial.
Immink JM, Putter H, Bartelink H, Cardoso JS, Cardoso MJ, van der Hulst-Vijgen MHV, Noordijk EM, Poortmans PM, Rodenhuis CC, Struikmans H. Immink JM, et al. Among authors: noordijk em. Ann Oncol. 2012 Oct;23(10):2591-2598. doi: 10.1093/annonc/mds066. Epub 2012 Apr 12. Ann Oncol. 2012. PMID: 22499858 Free article. Clinical Trial.
Techniques applied for total body irradiation.
Leer JW, Broerse JJ, De Vroome H, Chin A, Noordijk EM, Dutreix A. Leer JW, et al. Among authors: noordijk em. Radiother Oncol. 1990;18 Suppl 1:10-5. doi: 10.1016/0167-8140(90)90174-u. Radiother Oncol. 1990. PMID: 2247629 Review.
Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884).
Aleman BM, Girinsky T, van der Maazen RW, Strijk S, Meijnders P, Bortolus R, Olofsen-van Acht MJ, Lybeert ML, Lievens Y, Eghbali H, Noordijk EM, Tomsic R, Meerwaldt JH, Poortmans PM, Smit WG, Pinna A, Henry-Amar M, Raemaekers JM; European Organization for Research; Treatment of Cancer (EORTC) Lymphoma Group. Aleman BM, et al. Among authors: noordijk em. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1184-90. doi: 10.1016/j.ijrobp.2005.03.044. Epub 2005 Jun 2. Int J Radiat Oncol Biol Phys. 2005. PMID: 15936157
Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
Noordijk EM, Carde P, Dupouy N, Hagenbeek A, Krol AD, Kluin-Nelemans JC, Tirelli U, Monconduit M, Thomas J, Eghbali H, Aleman BM, Bosq J, Vovk M, Verschueren TA, Pény AM, Girinsky T, Raemaekers JM, Henry-Amar M. Noordijk EM, et al. J Clin Oncol. 2006 Jul 1;24(19):3128-35. doi: 10.1200/JCO.2005.05.2746. Epub 2006 Jun 5. J Clin Oncol. 2006. PMID: 16754934 Clinical Trial.
123 results